{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:09:09Z","timestamp":1794564549694,"version":"4.9.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:00:00Z","timestamp":1211241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background: <\/jats:bold> The pathogenesis of refractory ascites (RA) is linked to splanchnic vasodilation. We hypothesized that a combination of midodrine, octreotide long\u2010acting release (LAR) and albumin would result in increased natriuresis, better control of ascites and an improvement in renal function in patients with RA\u00b1Type 2 hepatorenal syndrome.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> A prospective pilot study in patients with RA as defined by the International Ascites Club. Consecutive patients received an intramuscular injection of octreotide\u2010LAR, 50\u2003g of albumin three times per week and midodrine titrated to increase the systolic blood pressure for 1 month.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Ten patients with RA were enrolled and eight with complete data to 1 month post\u2010treatment were included in the analysis. There was no change in renal function but there was a trend towards a reduction in the volume of ascites removed by paracentesis (<jats:italic>P<\/jats:italic>=0.08) and a significant reduction in the plasma renin (<jats:italic>P<\/jats:italic>=0.01) and aldosterone concentrations (<jats:italic>P<\/jats:italic>=0.01). Interestingly, there was a transient worsening in the model for end\u2010stage liver disease (MELD) score (<jats:italic>P<\/jats:italic>=0.01). The deterioration in MELD was completely reversible after discontinuation of therapy.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> To our knowledge, this is the first study of prolonged midodrine, octreotide and albumin therapy in RA. We observed a significant reduction in the plasma renin and aldosterone concentrations and a trend towards a reduction in the volume of ascites removed by paracentesis without an effect on renal function. The beneficial effects are at the expense of a reversible deterioration in the MELD score. Large controlled trials are needed before this therapy can be routinely recommended.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01778.x","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T04:56:42Z","timestamp":1269925002000},"page":"169-174","source":"Crossref","is-referenced-by-count":39,"title":["The effect \u2003of \u20031 \u2003month \u2003of \u2003therapy with midodrine, octreotide\u2010LAR and albumin in refractory ascites: a pilot study"],"prefix":"10.1111","volume":"29","author":[{"given":"Puneeta","family":"Tandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Tsuyuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoskinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mang M.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gutfreund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent G.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230122"},{"key":"e_1_2_7_3_2","first-page":"258","article-title":"The management of ascites in cirrhosis","volume":"38","author":"Moore KP","year":"2003","journal-title":"report of the consensus conference of the International Ascites Club"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365519850186346"},{"key":"e_1_2_7_5_2","first-page":"1151","article-title":"Peripheral arterial vasodilation hypothesis","volume":"8","author":"Schrier RW","year":"1988","journal-title":"a proposal for the initiation of renal sodium and water retention in cirrhosis"},{"key":"e_1_2_7_6_2","first-page":"635","article-title":"Quality of life in refractory ascites","volume":"42","author":"Campbell MS","year":"2005","journal-title":"transjugular intrahepatic portal-systemic shunting versus medical therapy"},{"key":"e_1_2_7_7_2","first-page":"004889","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","volume":"4","author":"Saab S","year":"2006","journal-title":"Cochrane Collab"},{"key":"e_1_2_7_8_2","first-page":"923","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"122","author":"Moreau R","year":"2002","journal-title":"a retrospective multicenter study"},{"key":"e_1_2_7_9_2","first-page":"152","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome","volume":"18","author":"Solanki P","year":"2003","journal-title":"a prospective, randomized placebo-controlled clinical trial"},{"key":"e_1_2_7_10_2","first-page":"694A","article-title":"A prospective, randomized, double\u2010blind placebo\u2010controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS)","volume":"44","author":"Sanyal A","year":"2006","journal-title":"Hepatology"},{"key":"e_1_2_7_11_2","first-page":"005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"4","author":"Gluud LL","year":"2006","journal-title":"a cochrane systematic review"},{"key":"e_1_2_7_12_2","first-page":"471","article-title":"Effects of a long\u2010acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension","volume":"34","author":"Ottesen LH","year":"2001","journal-title":"a randomized, double-blind, controlled trial"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21619"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280407"},{"key":"e_1_2_7_15_2","first-page":"941","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome","volume":"36","author":"Ortega R","year":"2002","journal-title":"results of a prospective, nonrandomized study"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341104"},{"key":"e_1_2_7_17_2","first-page":"461","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine","volume":"130","author":"Levey AS","year":"1999","journal-title":"a new prediction equation. Modification of diet in renal disease study group"},{"issue":"1","key":"e_1_2_7_18_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease","volume":"39","author":"National Kidney Foundation.","year":"2002","journal-title":"evaluation, classification and stratification"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.012"},{"key":"e_1_2_7_20_2","first-page":"639","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites","volume":"30","author":"Gentilini P","year":"1999","journal-title":"results of a randomized controlled trial"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80329-8"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510024043"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290629"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40899.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(87)80012-0"},{"key":"e_1_2_7_26_2","first-page":"1257","article-title":"Continuous prazosin administration in cirrhotic patients","volume":"109","author":"Albillos A","year":"1995","journal-title":"effects on portal hemodynamics and on liver and renal function"},{"key":"e_1_2_7_27_2","first-page":"499","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome","volume":"47","author":"Alessandria C","year":"2007","journal-title":"a prospective, randomized, unblinded, pilot study"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01778.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01778.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:27:15Z","timestamp":1697250435000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01778.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01778.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01778.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,6]]}}}